These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9474258)

  • 1. [From the COX-concept (Cyclooxygenase-2) to clinical gain. Meloxicam sets the standard. World-wide interactive video conference, London, 26 September 1997].
    Z Orthop Ihre Grenzgeb; 1997; 135(6 Suppl):1-4. PubMed ID: 9474258
    [No Abstract]   [Full Text] [Related]  

  • 2. [Selective cyclooxygenase-2 inhibitor].
    Hettich M; Thomae K
    Internist (Berl); 1997 Oct; 38(10):1007. PubMed ID: 9432492
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice.
    Lipsky PE; Abramson SB; Breedveld FC; Brook P; Burmester R; Buttgereit F; Cannon GW; Catella-Lawson F; Crofford LJ; Doherty M; Dougados M; DuBois RN; Froelich J; Garcia Rodriguez LA; Gibofsky A; Hernandez-Diaz S; Hochberg MC; Krause A; Liang MH; Machold K; Peloso PM; Raisz LG; Schayes B; Scheiman JM; Simon LS; Smolen J
    J Rheumatol; 2000 Jun; 27(6):1338-40. PubMed ID: 10852251
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
    Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
    Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rheumatic disease therapy without regret. Meloxicam dosage safety].
    MMW Fortschr Med; 2002 Nov; 144(46):66-7. PubMed ID: 12534086
    [No Abstract]   [Full Text] [Related]  

  • 6. COX-2 inhibitors. Magic bullets or merely mortal?
    Harv Health Lett; 2000 Feb; 25(4):4. PubMed ID: 10637015
    [No Abstract]   [Full Text] [Related]  

  • 7. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
    Oliw E; Wollheim FA
    Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
    [No Abstract]   [Full Text] [Related]  

  • 8. Rheumatoid arthritis treatment update.
    Johns Hopkins Med Lett Health After 50; 2000 Jan; 11(11):3. PubMed ID: 10614184
    [No Abstract]   [Full Text] [Related]  

  • 9. The new NSAIDs: cox-2 inhibitors.
    Capriotti T
    Medsurg Nurs; 2000 Dec; 9(6):313-7. PubMed ID: 11904867
    [No Abstract]   [Full Text] [Related]  

  • 10. Coming: a review of second-generation nonsteroidal anti-inflammatory drugs.
    Housholder GT; Chan JT
    J Gt Houst Dent Soc; 1997 Mar; 68(8):13-6. PubMed ID: 9594801
    [No Abstract]   [Full Text] [Related]  

  • 11. Meloxicam: new formulations and their use in rheumatology.
    Dequeker J; Degner F
    Inflamm Res; 2001 Mar; 50 Suppl 1():S3-4. PubMed ID: 11339518
    [No Abstract]   [Full Text] [Related]  

  • 12. Colorectal cancer chemoprevention: aspirin, other NSAID and COX-2 inhibitors.
    Kune GA
    Aust N Z J Surg; 2000 Jun; 70(6):452-5. PubMed ID: 10843404
    [No Abstract]   [Full Text] [Related]  

  • 13. Cox-2 inhibitors: a new class of medication?
    Habershaw TA
    Med Health R I; 1999 Sep; 82(9):332-4. PubMed ID: 10517079
    [No Abstract]   [Full Text] [Related]  

  • 14. [Meloxicam].
    Sternon J; Appelboom T
    Rev Med Brux; 1998 Feb; 19(1):29-32. PubMed ID: 9553452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationalizing cyclooxygenase inhibition for optimization of efficacy and safety profiles. Proceedings of a workshop. Fort Worth, Texas, USA. February 1999.
    Am J Med; 1999 Dec; 107(6A):1S-89S. PubMed ID: 10628587
    [No Abstract]   [Full Text] [Related]  

  • 16. Meloxicam--a safer NSAID?
    Drug Ther Bull; 1998 Aug; 36(8):62-4. PubMed ID: 9876404
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-steroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors].
    Miehle W
    Wien Med Wochenschr; 1999; 149(19-20):541-5. PubMed ID: 10637962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model.
    Hussey HJ; Tisdale MJ
    Int J Cancer; 2000 Jul; 87(1):95-100. PubMed ID: 10861458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclo-oxygenase 2 and breast cancer prevention. Non-steroidal anti-inflammatory agents are worth testing in breast cancer.
    Vainio H; Morgan G
    BMJ; 1998 Sep; 317(7162):828. PubMed ID: 9748169
    [No Abstract]   [Full Text] [Related]  

  • 20. [COX-2 inhibition: latest on NSAID].
    Z Orthop Ihre Grenzgeb; 1997; 135(1):Oa20-1. PubMed ID: 9199064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.